MiMedx
MDXG | NASDAQ
$3.18
-$0.03 (-0.93%)
At close: Nov 16, 2026, 4:00 PM ET
$3.19
+$0.01 (+0.31%)
After-hours:
Nov 16, 2026, 5:26 PM ET
-0.93%
(1D)No price chart data available for 1D timeframe.
Rating
30.2
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #796/1021 (Top 78%)
Key Statistics
Market Data
Market Cap $464.04M
1D Range
3.11 3.24
52W Range
3.09 7.25
Valuation (TTM)
PE -24.46
PB 2.20
EV/EBITDA -22.19
Valuation (NTM)
Forward PE 45.71
Forward PEG 0.15
Price Target $7.50
Cash Flow
FCF Yield 4.4%
SBC Adj. FCF Yield 3.3%
SBC Impact -24.0%
Margins
Gross Margin 77.3%
Operating Margin -8.3%
FCF Margin 6.7%
Growth (CAGR)
Revenue 3Y | 5Y -0.6% |
3.2%
Dil EPS 3Y | 5Y -147.9% |
52.1%
FCF 3Y | 5Y 38.5% |
54.0%
Returns
ROA -7.3%
ROE -8.3%
ROIC -9.7%
Financial Health
Net Cash
$120.79M
Current Ratio 4.35
Interest Coverage -22.71
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to...
Sector Healthcare
Industry Biotechnology
Employees 808
IPO Date Feb 12, 2008
Website www.mimedx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Oct 28, 2026
EPS
-$0.01
Miss -3671.43%
YoY:
-106.67% REV
$62.28M
Miss -9.16%
YoY:
-45.23%Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
5
Consensus
Buy
Price Target
$7.50
Upside
+135.85%
Buy (5)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MDXG